The role of cyclic nucleotide phosphodiesterases in the regulation of adipocyte lipolysis.
Peter B Snyder, James M Esselstyn, Kate Loughney, Sharon L Wolda, Vincent A Florio
文献索引:J. Lipid Res. 46(3) , 494-503, (2005)
全文:HTML全文
摘要
This study assessed the effects of selective inhibitors of 3',5'-cyclic nucleotide phosphodiesterases (PDEs) on adipocyte lipolysis. IC224, a selective inhibitor of type 1 phosphodiesterase (PDE1), suppressed lipolysis in murine 3T3-L1 adipocytes (69.6 +/- 5.4% of vehicle control) but had no effect in human adipocytes. IC933, a selective inhibitor of PDE2, had no effect on lipolysis in either cultured murine 3T3-L1 adipocytes or human adipocytes. Inhibition of PDE3 with cilostamide moderately stimulated lipolysis in murine 3T3-L1 and rat adipocytes (397 +/- 25% and 235 +/- 26% of control, respectively) and markedly stimulated lipolysis in human adipocytes (932 +/- 7.6% of control). Inhibition of PDE4 with rolipram moderately stimulated lipolysis in murine 3T3-L1 adipocytes (291 +/- 13% of control) and weakly stimulated lipolysis in rat adipocytes (149 +/- 7.0% of control) but had no effect on lipolysis in human adipocytes. Cultured adipocytes also responded differently to a combination of PDE3 and PDE4 inhibitors. Simultaneous exposure to cilostamide and rolipram had a synergistic effect on lipolysis in murine 3T3-L1 and rat adipocytes but not in human adipocytes. Hence, the relative importance of PDE3 and PDE4 in regulating lipolysis differed in cultured murine, rat, and human adipocytes.
相关化合物
相关文献:
2010-05-01
[PLoS Pathog. 6(5) , e1000897, (2010)]
2005-02-01
[J. Inorg. Biochem. 99(2) , 552-9, (2005)]
2006-01-01
[Nat. Protoc. 1(4) , 1761-71, (2006)]
2009-01-01
[PLoS ONE 4(2) , e4657, (2009)]
2009-11-01
[Rapid Commun. Mass Spectrom. 23(21) , 3423-30, (2009)]